Login to Your Account



Santarus' Zegerid For GERD: PPI Plus Antacid The Ticket?

By Randall Osborne


Monday, July 16, 2007
"GERD" might sound like the nickname of the nice German lady down the block who bakes Pfeffernusse cookies at Christmas, but physicians, biotech firms and a large number of unhappy patients know GERD as the acronym for gastroesophageal reflux disease, or acid reflux, an estimated $14 billion market. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription